parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.01 from other evidence	0.00
cell type Human Protein Atlas	group enriched, including microglia; strongest in choroid plexus epithelial cells	0.75
chemistry Open Targets	hard to drug	0.00
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	2 Parkinson's papers of 70	0.85
pathways Reactome	1 pathway; mostly other	0.30

No case: the score is under the bar. Receipt 8983

receipt 8991: RBM14 in dopamine neurons, braak

power: full sample -0.11 (p 0.652, n 18), 95% CI -0.55 to +0.37. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.14 (p 0.579, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.14 (p 0.579, n 18). could be the mix.
skeptic: leave-one-out range -0.23 to +0.02, sign flips 1; without severely affected donors -0.11 (p 0.652, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for RBM14 in dopamine neurons.

case closed: nothing better to follow up.

receipt 8990: RBM14 in microglia, braak

power: full sample +0.06 (p 0.807, n 18), 95% CI -0.42 to +0.51. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: +0.05 (p 0.854, n 18). does not hold up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.12 (p 0.646, n 18). could be the mix.
skeptic: leave-one-out range -0.07 to +0.22, sign flips 2; without severely affected donors +0.06 (p 0.807, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for RBM14 in microglia.

case closed: nothing better to follow up.

loading the receipts